Maryland Medicaid has officially updated its coverage policy to fully reimburse providers for administering the HPV vaccine (Gardasil 9) to eligible patients up to age 45. This significant policy change removes prior financial barriers and expands access to HPV-related cancer prevention for both adolescents and adults across the state.
What's Changed
Gardasil 9 is now fully covered for Maryland Medicaid and Medicaid MCO patients ages 9–45, with appropriate billing codes for reimbursement.
Key Points for Family Physicians
Clinical Action:
Take advantage of this expanded coverage by:
For more information, physicians can reference the full coverage and billing guide (PDF).
Read more News from MDAFP